Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term care

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F15%3A00083602" target="_blank" >RIV/00216224:14110/15:00083602 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/65269705:_____/15:00063185

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.ejca.2015.04.002" target="_blank" >http://dx.doi.org/10.1016/j.ejca.2015.04.002</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.ejca.2015.04.002" target="_blank" >10.1016/j.ejca.2015.04.002</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term care

Popis výsledku v původním jazyce

Survival after childhood cancer has improved substantially over recent decades. Although cancer in childhood is rare increasingly effective treatments have led to a growing number of long-term survivors. It is estimated that there are between 300,000 and500,000 childhood cancer survivors in Europe. Such good survival prospects raise important questions relating to late effects of treatment for cancer. Research has shown that the majority will suffer adverse health outcomes and premature mortality compared with the general population. While chronic health conditions are common among childhood cancer survivors, each specific type of late effect is very rare. Long-term effects must be considered particularly when addressing complex multimodality treatments, and taking into account the interaction between aspects of treatment and genotype. The PanCare Network was set up across Europe in order to effectively answer many of these questions and thereby improve the care and quality of life of

Název v anglickém jazyce

Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term care

Popis výsledku anglicky

Survival after childhood cancer has improved substantially over recent decades. Although cancer in childhood is rare increasingly effective treatments have led to a growing number of long-term survivors. It is estimated that there are between 300,000 and500,000 childhood cancer survivors in Europe. Such good survival prospects raise important questions relating to late effects of treatment for cancer. Research has shown that the majority will suffer adverse health outcomes and premature mortality compared with the general population. While chronic health conditions are common among childhood cancer survivors, each specific type of late effect is very rare. Long-term effects must be considered particularly when addressing complex multimodality treatments, and taking into account the interaction between aspects of treatment and genotype. The PanCare Network was set up across Europe in order to effectively answer many of these questions and thereby improve the care and quality of life of

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FD - Onkologie a hematologie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

European Journal of Cancer

ISSN

0959-8049

e-ISSN

—

Svazek periodika

51

Číslo periodika v rámci svazku

10

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

9

Strana od-do

1203-1211

Kód UT WoS článku

000355332000001

EID výsledku v databázi Scopus

—